<p>An overview of current and emerging PCSK9-directed therapies; their efficacy, safety, and role in clinical practice. Full text of the manuscript is available at: <a href="https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.4635" target="_blank" rel="noopener noreferer">https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.4635</a>. </p>

An overview of current and emerging PCSK9-directed therapies; their efficacy, safety, and role in clinical practice. Full text of the manuscript is available at: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.4635.

<p>An overview of current and emerging PCSK9-directed therapies; their efficacy, safety, and role in clinical practice. Full text of the manuscript is available at: <a href="https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.4635" rel="noopener noreferrer">https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.4635</a>. </p>

PCSK9-directed Therapies - Ep 152

This podcast brings you interviews with journal authors providing insight on their recent publication in an official journal of the American College of Clinical Pharmacy. Pharmacotherapy publishes advances in human pharmacology and drug therapy and the JACCP publishes innovations in clinical pharmacy practice.
ACCP JOURNALS DISCLAIM ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR ANY OTHER DAMAGES, INCLUDING LOSS OF PROFITS, ARISING OUT OF ANY USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE THE PODCAST, ITS CONTENTS AND MATERIALS.

Medicine

Health & Fitness

This podcast brings you interviews with journal authors providing insight on their recent publication in an official journal of the American College of Clinical Pharmacy. Pharmacotherapy publishes advances in human pharmacology and drug therapy and the JACCP publishes innovations in clinical pharmacy practice. ACCP JOURNALS DISCLAIM ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR ANY OTHER DAMAGES, INCLUDING LOSS OF PROFITS, ARISING OUT OF ANY USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE THE PODCAST, ITS CONTENTS AND MATERIALS.

Share PCSK9-directed Therapies - Ep 152

Sign up to save your podcasts

PCSK9-directed Therapies - Ep 152

PCSK9-directed Therapies - Ep 152

More shows like ACCP JOURNALS

EMCrit FOAM Feed

Gastropod

The Daily

Today, Explained